Prosetta Biosciences is a pioneering biotechnology company based in San Francisco, California, dedicated to revolutionizing drug discovery. Their innovative approach focuses on identifying and advancing novel small molecules that modulate the assembly of multi-protein complexes within cells, offering a new strategy for restoring molecular-level homeostasis and transforming the field of medicine.
With their cutting-edge Prosetta Platform, Prosetta Biosciences has successfully applied their technology to a wide range of infectious and degenerative diseases, including respiratory viruses like coronaviridae, Amyotrophic Lateral Sclerosis (ALS), oncology, Human Immunodeficiency Virus (HIV), and Parkinson's Disease. Through their groundbreaking work, Prosetta Biosciences is poised to shape the future of drug discovery and make significant contributions to the advancement of medical science.
Generated from the website